Trio Fertility
Toronto, Ontario, M5G 2K4, Canada
Location status: Recruiting
Location contact
Robert. F. Casper, Dr.
CONTACT
416-506-0804 ext. 3228
Robert. F. Casper, Dr.
CONTACT
Yasaman Sadeghi, M.Sc.
CONTACT
416-506-0804 ext. 2268
NCT Number: NCT06450301
The goal of this observational study is to determine if thin endometrial lining that is unresponsive to estrogen might be associated with the presence of senescent cells in patients following long-term use of oral contraceptives. The main question it aims to answer is:
Are there any senescent cells present in thin endometrial lining?
During the luteal phase of the cycle, participants will will undergo:
* Gynecologic US to measure the endometrial lining thickness and pattern. * Endometrial biopsy with Pipelle catheter
Interested in participating?
Request Info18 year–39 year
Female
Observational
Toronto, Ontario, M5G 2K4, Canada
Location status: Recruiting
Robert. F. Casper, Dr.
CONTACT
416-506-0804 ext. 3228
Robert. F. Casper, Dr.
CONTACT
Yasaman Sadeghi, M.Sc.
CONTACT
416-506-0804 ext. 2268
The investigators hypothesized that senescent cells in the endometrium may be the cause of the failure of thin endometrium to respond to normal growth stimuli such as estrogen.
The outcome that research team anticipate to measure is the percentage of senescent cells in the endometrial biopsies of women with thin endometrium compared to the control group biopsies.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An endometrial biopsy is the removal of a small piece of tissue from the endometrium, which is the lining of the uterus. Endometrial biopsies are commonly done to check for the window of implantation, to determine ovulation or for enhancing implantation (procedure called endometrial scratching). For this purpose, we will use a "Pipelle" catheter. This procedure is very common in gynecologic practice and
generally considered safe. In most of the cases this procedure is indicated for evaluation of irregular vaginal bleeding, vaginal bleeding in post-menopausal women and for infertility related problems (recurrent implantation failures for example).
Time frame: Through study completion, an average of 3 years.
Percentage of senescent cells in the endometrial biopsies of women with thin endometrium compared to the control group biopsies.
Trio Fertility
Other
Is Thin Endometrial Lining Associated with Senescent Endometrial Cells
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02708277
Asherman's Syndrome, Female Urogenital Diseases
View Trial DetailsNCT02144987
Asherman's Syndrome, Atrophy
Valencia, Spain
View Trial DetailsNCT07697924
Asherman Syndrome, Female Urogenital Diseases
Valencia, Spain
View Trial DetailsNCT07032506
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Little Rock, Arkansas, United States
View Trial Details